Abstract
Background
Late-onset myasthenia gravis (LOMG) is one of the major subgroups of the MG. Intensive evidence suggested that polymorphisms in HLA-DRB1 gene were associated with LOMG risk, but the results remained inconsistent. Therefore, a meta-analysis is conducted to make a more precise evaluation between HLA-DRB1 alleles and LOMG.
Methods
The PubMed, EMBASE, Cochrane library, Chinese National Knowledge Infrastructure (CNKI), and Wan Fang and Technology of Chongqing (VIP) Database were searched for eligible studies. The pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were applied to assess the association between HLA-DRB1 alleles and LOMG.
Results
A total of 11 studies involving 5513 people were included in our meta-analysis. The results showed that DRB1 07 and 0403 alleles were risk factors for LOMG (1.83 [1.12, 2.98], P = 0.02; 7.05 [2.62, 18.92], P = 0.0001, respectively), while DRB1 0301 and 1301 alleles were identified as protective factors for LOMG (0.44 [0.31, 0.62], P < 0.00001; 0.38 [0.23, 0.62], P = 0.0001, respectively). As for the HLA-DRB1 04 and 14 alleles, our subgroup analysis showed that there were significant associations between these alleles and LOMG in Caucasians (2.21 [1.14, 4.27], P = 0.02; 2.82 [1.29, 6.14], P = 0.009, respectively).
Conclusions
These results confirmed the association of DRB1 alleles (0301, 04, 0403, 07, 1301, and 14) and LOMG, which might provide potential promising biomarkers for prediction of LOMG risk.
Similar content being viewed by others
References
Chen L , Xie W , Zheng D , et al. Early extubation after thymectomy is good for the patients with myasthenia gravis[J].Neurological Sciences, 2019, 40(10):2125–2132
Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S (2016) Myasthenia gravis—autoantibody characteristics and their implications for therapy[J]. Nat Rev Neurol 12(5):259–268
Santos E, Bettencourt A, Da SA et al (2017) HLA and age of onset in myasthenia gravis[J]. Neuromuscul Disord 27(7):S0960896617300603
Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity[J]. Lancet Neurol 8(5):475–490
Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis[J]. Neurology 65(6):928–930
Casetta I, Groppo E, Gennaro RD et al (2010) Myasthenia gravis: a changing pattern of incidence[J]. J Neurol 257(12):2015–2019
Pallaver F, Riviera AP, Piffer S, Ricciardi R, Roni R, Orrico D, Bonifati DM (2011) Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years. Neuroepidemiology 36(4):282–287
Popperud TH, Viken MK, Kerty E et al (2017) Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.[J]. Plos One 12(10):e0186383
Avidan N, Le PR, Berrih-Aknin S et al (2014) Genetic basis of myasthenia gravis - a comprehensive review[J]. J Autoimmun 52:146–153
Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojyobori T (1992) Allele and haplotype frequencies for HLA and complement loci in various ethnic group, HLA 1991. Oxford: Oxford Press 1:1063–1220
Suzuki S, Utsugisawa K, Nagane Y et al (2011) Clinical and immunological differences between early and late-onset myasthenia gravis in Japan[J]. J Neuroimmunol 230(1):148–152
Xie YC, Qu Y, Sun L et al (2011) Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population[J]. J Clin Neurosci 18(11):1527
Testi M, Terracciano C, Guagnano A et al (2012) Association of HLA-DQB1*05:02 and DRB1*16 alleles with late-onset, nonthymomatous, AChR-Ab-positive myasthenia gravis[J]. Autoimmune Dis 2012(1):541760
Ehsan S, Amirzargar A, Yekaninejad MS, Mahmoudi M, Mehravar S, Moradi B, Nafissi S (2015) Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population[J]. J Neurol Sci 359(1–2):335–342
Baggi F, Antozzi C, Andreetta F et al (2010) Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population.[J]. Ann N Y Acad Sci 841(1):355–359
Fekihmrissa N, Klai S, Zaouali J et al (2013) Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.[J]. Clin Neurol Neurosurg 115(1):32–36
Maniaol AH, Elsais A, Lorentzen ÅR et al (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population[J]. PLoS One 7:e36603
Seldin MF, Alkhairy OK, Lee AT et al (2015) Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A, and identification of ZBTB10 and three distinct HLA associations[J]. Mol Med 21(1):769–781
Hui-yu F , Li-xuan Y , Wei-bin L , Xin H., Li Q , Yan L.The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population[J]. Neurological Sciences, 2015, 36(7):1135–1140
Massa R, Greco G, Testi M et al (2019) Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity[J]. J Neurol 266:982–989
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol 25(9):603–605
Reny J, Combescure C, Daali Y, Fontana P, PON1 Meta-Analysis Group (2012) Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis. J Thromb Haemost 10(7):1242–1251
Compston DA, Vincent A, Newsom-Davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103:579–601
Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P (2000) Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc 48:1442–1448
Akaishi T et al (2014) Insights into the classification of myasthenia gravis. PLoS One 9:e106757
Janer M, Cowland A, Picard J, Campbell D, Pontarotti P, Newsom-Davis J, Bunce M, Welsh K, Demaine A, Wilson AG, Willcox N (1999) A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C. Hum Immunol 60:909–917
Tremolizzo L, Giopato F, Piatti ML, Rigamonti A, Ferrarese C, Appollonio I.Myasthenia gravis mimicking stroke: a case series with sudden onset dysarthria[J]. Neurological Sciences, 2015, 36(6):895–898
Giraud M, Beaurain G, Yamamoto AM, Eymard B, Tranchant C, Gajdos P, Garchon HJ (2001) Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies[J]. Neurology 57(9):1555–1560
Romi F, Skeie GO, Aarli JA, Gilhus NE (2000) The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies[J]. Arch Neurol 57(11):1596–1600
Yamamoto AM, Gajdos P, Eymard B, Tranchant C, Warter JM, Gomez L, Bourquin C, Bach JF, Garchon HJ (2001) Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients[J]. Arch Neurol 58(6):885–890
Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Terayama Y, Suzuki N, Kuwana M (2007) Classification of myasthenia gravis based on autoantibody status[J]. Arch Neurol 64(8):1121–1124
Romi F, Gilhus NE, Varhaug JE et al (2010) Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.[J]. Ann N Y Acad Sci 998(1):481–490
Evoli A, Antonini G, Antozzi C et al (2019) Italian recommendations for the diagnosis and treatment of myasthenia gravis[J]. Neurol Sci 40:1111–1124
Abdelhafidh H, Almawi Wassim Y, Mouna S et al (2019) Association of HLA-DRB1 and -DQB1 alleles with type 1 (autoimmune) diabetes in African Arabs: systematic review and meta-analysis.[J]. Immunol Investig 48:130–146
Hong Y, Li HF, Romi F et al (2018) HLA and MuSK-positive myasthenia gravis: a systemic review and meta-analysis.[J]. Acta Neurol Scand:138(3)
Voight BF, Cotsapas C (2012) Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity [J]. Curr Opin Immunol 24(5):552–557
Parkes M, Cortes A, Heel DAV et al (2013) Genetic insights into common pathways and complex relationships among immune-mediated diseases[J]. Nat Rev Genet 14(9):661–673
Mahmoodi M, Nahvi H, Mahmoudi M, Kasaian A, Mohagheghi MA, Divsalar K, Nahavandian B, Jafari A, Ansarpour B, Moradi B, Aghamohammadi A, Amirzargar A (2012) HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer[J]. Pathology & Oncology Research 18(1):49–55
Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.[J]. Am J Hum Genet 74(1):160–167
Funding
This work was supported by grants from the National Science Foundation of China (Nos. 81460560 and 81960664) and the Applied Basic Research Program of Yunnan Province of China (No. 2017FB134).
Author information
Authors and Affiliations
Contributions
ML Shen and Y Wang reviewed the topic-related literature and performed the study concept and analysis design. CS Ling performed the data collection, wrote the first draft, analyzed, and interpreted the data. CS Ling, MLShen, Y Wang, WK Cai, XQ Lin, Q Huang, and GH He edited and GH He revised the manuscript. All authors checked interpreted results and approved the final version.
Corresponding author
Ethics declarations
All results and analyses were based on previous ethically-approved studies, thus no further ethical approval and patient consent are required.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
a Forest plots for association between HLA-DRB1 01 allele and LOMG in random model. b Forest plots for association between HLA-DRB1 1501 allele and LOMG in random model (TIF 1494 kb)
ESM 2
Forrest plots for association between HLA-DRB1 alleles and LOMG in six different alleles: a HLA-DRB1 03 allele. b HLA-DRB1 0701 allele. c HLA-DRB1 08 allele. d HLA-DRB1 09 allele. e HLA-DRB1 0901 allele. f HLA-DRB1 10 allele (TIF 3807 kb)
ESM 3
Forrest plots for association between HLA-DRB1 alleles and LOMG in six different alleles: a HLA-DRB1 11 allele. b HLA-DRB1 12 allele. c HLA-DRB1 13 allele. d HLA-DRB1 1302 allele. e HLA-DRB1 15 allele. f HLA-DRB1 16 (TIF 3879 kb)
ESM 4
Forest plots for association between HLA-DRB1 alleles and LOMG according to the ethnicity in four different alleles: a HLA-DRB1 01 allele. b HLA-DRB1 03 allele. c HLA-DRB1 08 allele. d HLA-DRB1 09 allele (TIF 4853 kb)
ESM 5
Forest plots for association between HLA-DRB1 alleles and LOMG according to the ethnicity in three different alleles: a HLA-DRB1 10 allele. b HLA-DRB1 11 allele. c HLA-DRB1 12 allele (TIF 3726 kb)
ESM 6
Forest plots for association between HLA-DRB1 alleles and LOMG according to the ethnicity in three different alleles: a HLA-DRB1 13 allele. b HLA-DRB1 15 allele. c HLA-DRB1 16 allele (TIF 3664 kb)
ESM 7
(DOCX 16 kb)
Rights and permissions
About this article
Cite this article
Ling, CS., Shen, ML., Wang, Y. et al. The associations of HLA-DRB1 gene polymorphisms with late-onset myasthenia gravis: a meta-analysis. Neurol Sci 41, 1041–1049 (2020). https://doi.org/10.1007/s10072-019-04213-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-04213-7